QIAGEN N.V. Reports Change in Certifying Accountant
Ticker: QGEN · Form: 6-K · Filed: Nov 8, 2024 · CIK: 1015820
| Field | Detail |
|---|---|
| Company | Qiagen N.V. (QGEN) |
| Form Type | 6-K |
| Filed Date | Nov 8, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: auditor-change, reporting
TL;DR
QIAGEN auditor change filed. Keep an eye on financial reporting.
AI Summary
QIAGEN N.V. filed a Form 6-K on November 8, 2024, reporting changes related to its certifying accountant for the period ending October 31, 2024. The filing indicates a change in the company's auditor, though specific details of the change or the new auditor are not provided in this excerpt.
Why It Matters
Changes in a company's auditor can signal potential shifts in financial reporting scrutiny or internal control assessments, which are important for investor confidence.
Risk Assessment
Risk Level: low — This filing is procedural and does not contain information that directly impacts the company's financial performance or operations.
Key Players & Entities
- QIAGEN N.V. (company) — Registrant
- 001-38332 (company) — SEC File Number
- 20241031 (date) — Report Period End Date
- 20241108 (date) — Filing Date
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose of this Form 6-K filing is to report a change in QIAGEN N.V.'s certifying accountant.
What period does this report cover?
This report covers the period ending October 31, 2024.
When was this filing submitted to the SEC?
This filing was submitted to the SEC on November 8, 2024.
What is QIAGEN N.V.'s principal executive office address?
QIAGEN N.V.'s principal executive office is located at Hulsterweg 82, 5912 PL Venlo, The Netherlands.
Does QIAGEN N.V. file annual reports under Form 20-F or 40-F?
QIAGEN N.V. indicates it files annual reports under cover of Form 20-F.
Filing Stats: 320 words · 1 min read · ~1 pages · Grade level 12.5 · Accepted 2024-11-07 18:11:49
Filing Documents
- a2024form6-kchangeinaccoun.htm (6-K) — 17KB
- 0001015820-24-000091.txt ( ) — 18KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. QIAGEN N.V. By s Roland Sackers Roland Sackers Chief Financial Officer Date November 7, 2024 4